Increased YKL-40 but Not C-Reactive Protein Levels in Patients with Alzheimer's Disease.

Alzheimer’s disease C-reactive protein CSF and plasma biomarkers Parkinson’s disease YKL-40 astrogliosis inflammation

Journal

Biomedicines
ISSN: 2227-9059
Titre abrégé: Biomedicines
Pays: Switzerland
ID NLM: 101691304

Informations de publication

Date de publication:
27 Aug 2021
Historique:
received: 21 07 2021
revised: 16 08 2021
accepted: 23 08 2021
entrez: 28 9 2021
pubmed: 29 9 2021
medline: 29 9 2021
Statut: epublish

Résumé

Neuroinflammation is a common feature in Alzheimer's (AD) and Parkinson's (PD) disease. In the last few decades, a testable hypothesis was proposed that protein-unfolding events might occur due to neuroinflammatory cascades involving alterations in the crosstalk between glial cells and neurons. Here, we tried to clarify the pattern of two of the most promising biomarkers of neuroinflammation in cerebrospinal fluid (CSF) in AD and PD. This study included cognitively unimpaired elderly patients, patients with mild cognitive impairment, patients with AD dementia, and patients with PD. CSF samples were analyzed for YKL-40 and C-reactive protein (CRP). We found that CSF YKL-40 levels were significantly increased only in dementia stages of AD. Additionally, increased YKL-40 levels were found in the cerebral orbitofrontal cortex from AD patients in agreement with augmented astrogliosis. Our study confirms that these biomarkers of neuroinflammation are differently detected in CSF from AD and PD patients.

Identifiants

pubmed: 34572280
pii: biomedicines9091094
doi: 10.3390/biomedicines9091094
pmc: PMC8467854
pii:
doi:

Types de publication

Journal Article

Langues

eng

Subventions

Organisme : Instituto de Salud Carlos III
ID : FIS18/00118
Organisme : Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas
ID : CB07/502
Organisme : Instituto de Salud Carlos III
ID : CM 18/0095
Organisme : Consejería de Educación e Investigación
ID : S2017/BMD-3700

Références

Acta Neurol Belg. 2012 Jun;112(2):155-9
pubmed: 22426659
Biol Psychiatry. 2010 Nov 15;68(10):930-41
pubmed: 20692646
Am J Alzheimers Dis Other Demen. 2016 May;31(3):194-200
pubmed: 26340961
Acta Neuropathol. 2017 Nov;134(5):789-808
pubmed: 28725967
Nat Med. 2008 May;14(5):501-3
pubmed: 18391963
Parkinsonism Relat Disord. 2004 May;10 Suppl 1:S3-7
pubmed: 15109580
J Immunol. 2008 Oct 1;181(7):5167-73
pubmed: 18802121
Acta Neuropathol. 2010 Jan;119(1):7-35
pubmed: 20012068
Neurosci Lett. 1994 Aug 15;177(1-2):23-6
pubmed: 7824175
Biochem Biophys Res Commun. 2012 Sep 14;426(1):112-5
pubmed: 22917537
Lancet Neurol. 2009 Apr;8(4):382-97
pubmed: 19296921
Adv Neurol. 2001;86:83-9
pubmed: 11554012
Dement Geriatr Cogn Dis Extra. 2014 Jul 31;4(2):297-304
pubmed: 25254036
Oncogene. 2009 Dec 17;28(50):4456-68
pubmed: 19767768
Neurology. 2018 Aug 28;91(9):e867-e877
pubmed: 30054439
Alzheimers Dement. 2011 May;7(3):270-9
pubmed: 21514249
Front Immunol. 2020 Jan 31;11:33
pubmed: 32082315
Mol Neurobiol. 2014 Oct;50(2):534-44
pubmed: 24567119
Sci Rep. 2018 Sep 5;8(1):13276
pubmed: 30185816
Neurosci Lett. 2020 Jan 10;715:134658
pubmed: 31794792
Biol Psychiatry. 2010 Nov 15;68(10):903-12
pubmed: 21035623
N Engl J Med. 1999 Feb 11;340(6):448-54
pubmed: 9971870
J Mol Neurosci. 2016 Nov;60(3):316-324
pubmed: 27498201
J Alzheimers Dis. 2014;42(3):901-8
pubmed: 25024322
Sci Rep. 2020 Apr 21;10(1):6682
pubmed: 32317654
J Neuroinflammation. 2019 Feb 21;16(1):46
pubmed: 30791945
J Gerontol A Biol Sci Med Sci. 2013 Apr;68(4):433-40
pubmed: 22982688
J Neuroinflammation. 2006 Sep 27;3:27
pubmed: 17005052
J Alzheimers Dis. 2010;22(4):1073-9
pubmed: 20930309
Stroke. 2014 Jan;45(1):59-65
pubmed: 24262327
Inflamm Res. 2006 Jun;55(6):221-7
pubmed: 16955240
Cardiovasc Diabetol. 2009 Nov 23;8:61
pubmed: 19930630
Mol Neurodegener. 2017 Nov 10;12(1):83
pubmed: 29126445
Lancet Neurol. 2015 Apr;14(4):388-405
pubmed: 25792098
J Hepatol. 2000 Jun;32(6):911-20
pubmed: 10898311
Neurobiol Dis. 2010 Mar;37(3):510-8
pubmed: 19913097
Alzheimers Res Ther. 2018 Feb 26;10(1):25
pubmed: 29482610
Mov Disord. 2015 Oct;30(12):1591-601
pubmed: 26474316
Front Neurol. 2019 Apr 17;10:384
pubmed: 31057478
Eur Neurol. 2014;72(5-6):285-9
pubmed: 25323302
Neurobiol Aging. 2001 Nov-Dec;22(6):843-8
pubmed: 11754991
Transl Neurodegener. 2018 Sep 10;7:23
pubmed: 30311914
J Neuroinflammation. 2017 Jun 9;14(1):118
pubmed: 28599675
Brain Res. 1997 Feb 21;749(1):152-6
pubmed: 9070642
Science. 2016 Aug 19;353(6301):777-83
pubmed: 27540165
Neurology. 2012 Aug 14;79(7):690-9
pubmed: 22855859
J Neuroinflammation. 2010 Jun 11;7:34
pubmed: 20540736
Neurobiol Aging. 2015 Jun;36(6):2018-23
pubmed: 25865441
Neurobiol Aging. 2009 Nov;30(11):1885-9
pubmed: 18378357
Cytokine. 2016 Jan;77:227-37
pubmed: 26463515
Alzheimers Dement. 2016 Jun;12(6):719-32
pubmed: 27179961
J Cereb Blood Flow Metab. 2015 May;35(5):747-50
pubmed: 25757748
Rheumatology (Oxford). 2006 May;45(5):522-6
pubmed: 16319098
Mov Disord. 2013 Nov;28(13):1882-5
pubmed: 23847144
J Biol Chem. 2003 Nov 7;278(45):44058-67
pubmed: 12933821
Alzheimers Dement. 2012 Jan;8(1):1-13
pubmed: 22265587
Ann N Y Acad Sci. 2009 Feb;1153:240-6
pubmed: 19236346
J Intern Med. 2004 Sep;256(3):240-6
pubmed: 15324367
Brain Pathol. 2012 Jul;22(4):530-46
pubmed: 22074331
Neurology. 1993 Nov;43(11):2412-4
pubmed: 8232972
Alzheimers Dement. 2011 May;7(3):263-9
pubmed: 21514250
Front Immunol. 2018 Jun 07;9:1302
pubmed: 29951057
Neurotherapeutics. 2010 Oct;7(4):399-412
pubmed: 20880504
Brain Res. 2000 Dec 22;887(1):80-9
pubmed: 11134592
Mov Disord. 2016 Jul;31(7):995-1003
pubmed: 26999434
Parkinsonism Relat Disord. 2015 Dec;21(12):1398-406
pubmed: 26493111

Auteurs

Víctor Antonio Blanco-Palmero (VA)

Network Center for Biomedical Research in Neurodegenerative Diseases (CIBERNED), 28031 Madrid, Spain.
Group of Neurodegenerative Diseases, Hospital 12 de Octubre Research Institute (imas12), 28041 Madrid, Spain.
Neurology Service Hospital Universitario 12 de Octubre, 28041 Madrid, Spain.

Marcos Rubio-Fernández (M)

Network Center for Biomedical Research in Neurodegenerative Diseases (CIBERNED), 28031 Madrid, Spain.
Group of Neurodegenerative Diseases, Hospital 12 de Octubre Research Institute (imas12), 28041 Madrid, Spain.

Desireé Antequera (D)

Network Center for Biomedical Research in Neurodegenerative Diseases (CIBERNED), 28031 Madrid, Spain.
Group of Neurodegenerative Diseases, Hospital 12 de Octubre Research Institute (imas12), 28041 Madrid, Spain.

Alberto Villarejo-Galende (A)

Network Center for Biomedical Research in Neurodegenerative Diseases (CIBERNED), 28031 Madrid, Spain.
Group of Neurodegenerative Diseases, Hospital 12 de Octubre Research Institute (imas12), 28041 Madrid, Spain.
Neurology Service Hospital Universitario 12 de Octubre, 28041 Madrid, Spain.

José Antonio Molina (JA)

Network Center for Biomedical Research in Neurodegenerative Diseases (CIBERNED), 28031 Madrid, Spain.
Group of Neurodegenerative Diseases, Hospital 12 de Octubre Research Institute (imas12), 28041 Madrid, Spain.
Neurology Service Hospital Universitario 12 de Octubre, 28041 Madrid, Spain.

Isidro Ferrer (I)

Network Center for Biomedical Research in Neurodegenerative Diseases (CIBERNED), 28031 Madrid, Spain.
Bellvitge Biomedical Research Institute (IDIBELL), Hospitalet de Llobregat, E08907 Barcelona, Spain.
Department of Pathology and Experimental Therapeutics, University of Barcelona, E08900 Barcelona, Spain.
Institute of Neurosciences, University of Barcelona, E08000 Barcelona, Spain.

Fernando Bartolome (F)

Network Center for Biomedical Research in Neurodegenerative Diseases (CIBERNED), 28031 Madrid, Spain.
Group of Neurodegenerative Diseases, Hospital 12 de Octubre Research Institute (imas12), 28041 Madrid, Spain.

Eva Carro (E)

Network Center for Biomedical Research in Neurodegenerative Diseases (CIBERNED), 28031 Madrid, Spain.
Group of Neurodegenerative Diseases, Hospital 12 de Octubre Research Institute (imas12), 28041 Madrid, Spain.

Classifications MeSH